Prof. Vasilis Ntziachristos is a Professor and Chair of Biological Imaging at the Technical University of Munich (TUM), leading the Institute of Biological and Medical Imaging at the Helmholtz Centre Munich. His research focuses on developing novel optical and optoacoustic imaging techniques for early disease detection, diagnostics, and theranostics. He holds a PhD in Bioengineering from the University of Pennsylvania and previously served as an Assistant Professor at Harvard University and Massachusetts General Hospital. Affiliations: TUM School of Medicine and Health, Helmholtz Munich, Institute of Biological and Medical Imaging. Key Research Themes: Non-invasive imaging methods, molecular imaging, optoacoustic technology, and clinical translation. His work bridges theoretical developments with clinical applications, including advancements in glucose monitoring, cancer imaging, and drug delivery systems. Notable awards include the Leibniz Prize (2013) and the World Molecular Imaging Society Gold Medal (2015). Labs/Teams: Imaging to Sensing I2S, Optoacoustic Mesoscopy, Fluorescence Imaging, and AI in Optoacoustics. Grants/Projects: Involvement in Horizon Europe initiatives and collaborations with TranslaTUM and Helmholtz Munich. Prof. Ntziachristos actively contributes to education via courses like 'Biological Imaging' and 'Introduction to Bioengineering', fostering the next generation of imaging scientists.
Sachdev Sidhu is a Research Professor and Entrepreneur in Residence at the University of Waterloo. His research focuses on synthetic antibodies, protein engineering, and biotechnological applications. He leads efforts in developing novel therapeutic antibodies, engineered protein systems, and molecular tools for biomedical research. His work spans cancer therapy, viral infection countermeasures, and regenerative medicine. Sidhu is also involved in translational research, bridging academic discoveries with commercial applications through entrepreneurial ventures. Key research interests include synthetic antibody libraries, CAR T-cell engineering, ubiquitin-based therapeutics, and phage display technologies. He has contributed to advancements in targeted therapies for glioblastoma, leukemia, and ocular diseases. His team develops innovative methods for protein design, such as engineered ubiquitin variants and modular antibody architectures. Publications highlight breakthroughs in antibody-based treatments, including synNotch CAR T cells for glioblastoma and neutralizing antibodies against SARS-CoV-2. His work integrates structural biology, molecular biology, and computational approaches to address complex biomedical challenges. Sidhu collaborates with industry partners to advance technologies into clinical and commercial settings.
Virgil Percec is the P. Roy Vagelos Professor of Chemistry at the University of Pennsylvania, affiliated with the School of Arts & Sciences and the Department of Chemistry. His research focuses on organic, supramolecular, and macromolecular chemistry, with an emphasis on self-assembly, drug delivery systems, and biomimetic nanosystems. He holds a B.S. and Ph.D. from institutions in Jassy, Romania, and conducted postdoctoral research at the University of Freiburg and the University of Akron. Research Interests: Percec’s work integrates synthetic methods, catalysis, and structural biology to design functional nanosystems. Key areas include hierarchical folding, supramolecular chirality, and synthetic mimics of biological membranes. His lab explores mRNA delivery systems using Janus dendrimers and studies self-organized structures like helical columns and quasicrystals. Recent Articles: His recent publications highlight advancements in mRNA delivery mechanisms, supramolecular architectures, and polymer synthesis innovations. The group’s work often involves interdisciplinary collaborations, bridging chemistry, materials science, and bioengineering. Awards: Percec was elected a Foreign Member of the Academia Europaea (2020) and delivered the inaugural ACS Kavli Lecture (2011). His lab has trained numerous students and postdocs, including Juncheng Lu (Master’s Capstone Award recipient) and Devendra Maurya (SET-LRP research). Labs & Teams: The Percec Research Laboratory at Penn develops cutting-edge biomaterials and supramolecular systems. The group collaborates globally, with projects funded by grants exploring nanotechnology and drug delivery.
Zhiling Gu is a Research Fellow at Yale School of Public Health, having earned her Ph.D. in Statistics at Iowa State University. Her work integrates statistical theory with applications in public health and medicine. Her research spans Functional Data Analysis Network Analysis Spatiotemporal Modeling Statistical AI Foundations Nonparametric Learning applied to neuroimaging, electronic health records, and environmental health studies. Recent publications focus on Adaptive spatiotemporal models Neuroimaging data processing Pandemic forecasting frameworks Environmental exposure modeling with methodological rigor and practical implementation. Scientific achievements include Runner-up in SMI 2023 Student Paper Competition She has taught STAT 305: Engineering Statistics (ISU) STAT 226: Business Statistics Statistical Computing Statistical Learning and actively engages in academic presentations at conferences like SMI 2024 and CMStatistics 2022.
Andrew D. White is an Associate Professor of Chemical Engineering at the Hajim School of Engineering & Applied Sciences, University of Rochester. He holds a PhD from the University of Washington (2013). His research focuses on automating scientific discovery through AI, particularly leveraging large language models (LLMs) and deep learning techniques in chemistry. His lab develops agents that integrate literature analysis, hypothesis generation, and experimental design to advance fields like molecular dynamics and drug discovery. Education: PhD in Chemical Engineering, University of Washington, 2013 BS/MS (not explicitly stated in text, inferred from career timeline) Research Interests: Large language models for scientific automation Deep learning applications in chemistry and materials science Molecular dynamics simulations Scientific agents and autonomous systems Publications: His work includes groundbreaking studies on closed-loop AI systems for chemistry, federated learning in molecular property prediction, and multi-agent systems for drug discovery. Recent highlights include the Robin system and ChemCrow tools. Awards: Recipient of the NSF Career Award (2018), NIH Outstanding Investigator Award (2020), and the Curtis Teaching Award (2019). He also advises biotech companies and serves on the National Academy of Sciences' Chemical Sciences Roundtable. Grants & Funding: Supported by DOE, NSF (multiple grants including CBET-1751471), NIH (R35GM137966), and LLNL projects. Collaborates with institutions like Argonne National Lab and Qubit Pharmaceuticals. Labs & Teams: Leads the White Lab at Rochester and co-founded FutureHouse, a nonprofit advancing AI-driven scientific discovery. Supervises a multidisciplinary team of PhD students and postdocs in computational chemistry, AI, and biophysics.
Martin Burke is the May and Ving Lee Professor for Chemical Innovation and Professor of Chemistry at the University of Illinois Urbana-Champaign , with additional appointments in Biochemistry, Biomedical & Translational Sciences, and multiple campus institutes including the Beckman Institute and the Carl R. Woese Institute for Genomic Biology. Education B.S. Johns Hopkins University , 1998 Ph.D. Harvard University , 2003 M.D. Harvard Medical School , 2003 Research Interests Burke’s program centers on molecular prosthetics : the design, synthesis and application of small molecules that replicate or replace missing or dysfunctional proteins. His group pioneered iterative cross-coupling (ICC) using MIDA-protected haloboronic acids to automate the construction of complex natural products and function-oriented small molecules. Current projects target ion-channel replacement in cystic fibrosis, iron-transport restoration in anemia, and non-toxic antifungals that overcome drug resistance. Scientific Awards & Honors National Academy of Medicine (2021) AAAS Fellow (2021) ASCI Member (2021) iCON Award (2019) Mukaiyama Award, Japan (2019) ACS Nobel Laureate Award for Graduate Education (2017) Thieme-IUPAC Prize in Synthetic Organic Chemistry (2014) Elias J. Corey Award (2013) Arthur C. Cope Scholar Award (2011) Research Output & Impact Burke has authored >120 peer-reviewed articles, >30 patents, and his work has been cited >20,000 times. High-impact publications in Nature , Science , and Angewandte Chemie have advanced automated synthesis, molecular prosthetics, and cystic fibrosis therapeutics. Laboratory & Training The Burke Laboratories house a multidisciplinary team of graduate students, post-doctoral researchers, and physician-scientists developing next-generation molecular prosthetics. The group is supported by NIH, NSF, private foundations, and industry partnerships aimed at democratizing molecular innovation.
Lucia Carichino is an Assistant Professor in the School of Mathematics and Statistics at Rochester Institute of Technology (RIT). She holds a PhD in Mathematics from Purdue University and a BS/MS in Mathematical Engineering from Politecnico di Milano, Italy. Her research focuses on mathematical and computational models of multiscale biological systems, particularly fluid-structure interaction in biological contexts like ocular blood flow and microswimmers. She emphasizes integrating experimental data with mathematical models to advance medical understanding. Carichino teaches courses such as Differential Equations, Linear Algebra, and oversees undergraduate research projects. In 2023, she received the National Science Foundation LEAPS-MPS award for her work on computational modeling of eye-contact lens interactions. Her research has been published in high-impact journals and presented at conferences. She actively collaborates on projects addressing glaucoma, ocular hemodynamics, and biomedical applications. Education: PhD in Mathematics, Purdue University BS and MS in Mathematical Engineering, Politecnico di Milano, Italy Research interests include fluid dynamics, numerical methods, and mathematical biology. Her work bridges theoretical models with biomedical applications, such as optimizing gene therapy delivery and analyzing ocular physiology under varying environmental conditions (e.g., altitude). She explores topics like sperm motility, computational simulations of biological systems, and the interplay between fluid dynamics and biological structures. Her recent articles highlight advancements in ocular pharmacokinetics, contact lens interactions, and altitude effects on intraocular pressure. These studies underscore her expertise in multiscale modeling and fluid-structure interaction. Carichino also contributes to educational initiatives, fostering a collaborative classroom environment. Notable awards include the NSF LEAPS-MPS award (2023). She advises student research projects and collaborates with colleagues, such as Maki, on interdisciplinary studies. Her work is supported by grants and has led to presentations at ophthalmology and mathematics conferences. Carichino’s lab focuses on computational modeling of biological systems, particularly in ophthalmology and microscale fluid dynamics. Her team develops tools to simulate complex physiological processes, aiding in medical diagnostics and treatment strategies.
Lee Yong Lim is a Professor of Pharmaceutics at The University of Western Australia (UWA), leading the Laboratory for Drug Delivery. She specializes in innovative drug delivery systems, particularly for pediatric populations and marine aquaculture. Her work focuses on overcoming medication challenges for children through taste-masked formulations and stable drug-loaded scaffolds for ear diseases. She has secured over $4.5 million in research grants from diverse funding bodies. Education: BSc (Pharmacy) Hons, National University of Singapore PhD, University of Manchester Research: Her team developed a patented chocolate-based formulation for bitter drugs and conducts pediatric trials. Collaborations include WA hospitals for safe compounded medicines and international projects in nanotechnology. Key research areas include pediatric medicinal products, veterinary drug delivery, and sustainable drug formulations aligned with UN SDGs. Grants & Funding: Major supporters include NHMRC, ARC, Telethon, and industry partnerships. Current active grants focus on pre-procedural chewables for children and perioperative analytics. Labs/Teams: Heads the Laboratory for Drug Delivery and collaborates with the Centre for Optimisation of Medicines and Institute for Paediatric Perioperative Excellence.
Dr. Julie N.L. Albert is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at Tulane University, holding the Robert and Gayle Longmire Early Career Professorship. She is affiliated with the School of Science and Engineering and serves as co-director of the SMART REU NSF-funded program. Her research focuses on engineering nano- and micro-structured polymeric materials for energy, health, and environmental applications, emphasizing self-assembly processes in block copolymers and polymer blends. Key areas include nanoporous membranes, biocompatible surfaces, and stimuli-responsive materials. Dr. Albert earned her B.S. in Chemical Engineering from the University of Florida (2005) and her Ph.D. from the University of Delaware (2012). She conducted postdoctoral research at North Carolina State University. Her work has been supported by prestigious grants, including the NSF CAREER Award and a Gulf Research Program Fellowship. Her research group explores topics like polymer crystallization, polyorganosiloxanes, and block copolymer architectures. Notable achievements include developing methods for controlling polymer morphology via solvent vapor annealing and surface chemistry gradients. She advises numerous graduate and undergraduate students and mentors organizations like the Society of Women Engineers. Education: B.S., Chemical Engineering, University of Florida, 2005 Ph.D., Chemical Engineering, University of Delaware, 2012 Research Interests: Self-assembly of block copolymers, nanoporous membranes, biocompatible materials, and energy applications. Awards: NSF Graduate Research Fellowship, Gulf Research Program Early-Career Fellowship, AIChE Travel Award. Dr. Albert’s lab houses advanced facilities such as AFM, spectral reflectometry, and GPC, enabling cutting-edge polymer characterization. Her contributions bridge polymer science, materials engineering, and environmental sustainability, addressing challenges in energy recovery and biomedical technologies.
Karl Griswold is a Professor of Engineering at Dartmouth College's Thayer School of Engineering, where he leads the Griswold Research Group focused on protein engineering and biotherapeutics development. His interdisciplinary work spans chemical, biological, and engineering disciplines to address critical challenges in drug-resistant infections and protein therapeutics. Education: BS in Chemistry from Southwest Texas State University (1995) PhD in Chemistry from the University of Texas at Austin (2005) Research Focus: Professor Griswold's laboratory specializes in protein engineering, directed evolution, and biotherapeutics development , creating novel biomolecules with superior functionality compared to natural proteins. The group develops high-throughput screening methods, protein deimmunization strategies, enhanced expression systems, and antibacterial agents targeting drug-resistant infections. Their work has significant translational potential for treating conditions like MRSA and Pseudomonas aeruginosa infections. Scientific Recognition: Wallace H. Coulter Foundation Early Career Translational Research Award in Biomedical Engineering (2008) NIH Biotechnology Training Grant (2000-2003) Royston M. Roberts - Regents Fellowship, University of Texas (1999) DOW Chemical Foundation Scholar, Texas State University (1991-1995) Senior Fellow, National Academy of Inventors Research Leadership: As co-founder and CEO of Stealth Biologics, Professor Griswold translates academic research into commercial applications. His work has secured NIH funding and Dartmouth Innovations Accelerator support, with research featured in Chemical & Engineering News, Vermont Public Radio, and the New Hampshire Union Leader for developing alternatives to traditional antibiotics. Research Environment: The Griswold Research Group maintains extensive collaborations across disciplines including clinical medicine, immunology, structural biology, and chemical engineering. This interdisciplinary approach prepares trainees for careers at the intersection of multiple scientific fields, with research focusing on Biomolecular Antimicrobial Therapies, Deimmunizing Protein Therapeutics, and Gene Library Construction Technologies.
Vishal Ahuja is an Associate Professor and Corrigan Research Professor at Southern Methodist University's Cox School of Business, with adjunct faculty status at University of Texas Southwestern Medical Center. He focuses on decision analytic tools for healthcare improvement through operations management. PhD, University of Chicago Booth School of Business MBA, University of Chicago Booth School of Business His research interests span healthcare operations, service optimization, and AI applications in clinical decision-making. He collaborates with the Department of Veterans Affairs, Parkland Hospital, and pediatric institutions to address care quality and delivery efficiency. Recent publications emphasize predictive modeling for chronic disease management, adaptive clinical trial design, and regulatory healthcare policy. Awards include the Dlin/Fischer Clinical Research Award (2021), INFORMS Pierskalla Award (2012), and 2025 AI75 recognition for Dallas-Fort Worth AI leadership. D CEO Excellence in Healthcare Award - Outstanding Healthcare Innovator (2023) NSF Game Changer Academies for Advancing Research Innovation (2022) C. Jackson Grayson Faculty Innovation Award (2022-23) At SMU, he teaches graduate courses in operations, supply chain, and service management, integrating corporate sector experience from chemical and consumer goods industries. His work has been cited by the FDA in safety labeling changes workshops.
Eileen Klein is an Associate Professor of Social Work and Convener of the BSW Program at Ramapo College of New Jersey's School of Social Science and Human Services. Her work focuses on LGBTQ mental health treatment , community support systems , and policy reform for marginalized populations. Klein has presented extensively at international conferences on topics like cultural competency in social work education and LGBTQ health disparities . Ph.D., M.S., and M.S.W. from New York University and SUNY Buffalo Key research areas: LGBTQ Mental Health, Community Health Disparities, Forensic Social Work Published 15+ works (2013-2021) on topics ranging from polypharmacy to support programs for LGBTQ clients Active in professional development: Delivered presentations at conferences across the U.S. and Italy on topics including integrated treatment and supervision of student interns
Prof. Raul Fangueiro is a Full Professor and Vice-Dean at the School of Engineering, University of Minho, Portugal. As a Senior Researcher, he leads FIBRENAMICS – Institute of Innovation on Fiber-Based Materials and Composites. His work spans advanced materials (nano, smart, composites) and structures (3D, auxetic, multiscale) with applications in defense, healthcare, construction, and automotive sectors. Supervised over 20 PhD and Post-Doc researchers Scientific coordinator of 20+ national/international research projects Author of 200+ journal papers (H-index: 47), 500+ conference publications, 36 books, 40 patents Research focuses on nanotechnology , electrospinning , and sustainable material systems : Auxetic composites for personal protection Biodegradable nanofibers for medical use Smart textiles for biological/chemical resistance Recycled mineral/wood-based composites Graphene-reinforced green materials Multiscale fiber architectures Scientific recognition includes: Top 2% most influential scientist (Elsevier/Stanford 2020) Founder of AUXDEFENSE and ICNF conferences Editorial board member of leading composite journals Advisor to European Defense Agency/NATO working groups Active in industry-academia partnerships through spin-offs (Sciencentris, B4Logic, Beyond Composites, Givaware, Pixartidea) and collaborative projects with institutions like Instituto Superior Técnico, University of Aveiro, and international universities.
Yuankai (Kenny) Tao is an Associate Professor of Biomedical Engineering at Vanderbilt University's School of Engineering and an SPIE Faculty Fellow. He directs the Graduate Studies program in Biomedical Engineering and leads research in optical imaging systems for clinical diagnostics and therapeutic monitoring in ophthalmology, gastroenterology, and oncology. His lab develops technologies like intraoperative OCT and SECTR, focusing on noninvasive subcellular visualization and biomarker monitoring. Collaborations span engineering, basic sciences, and medicine to translate innovations into clinical tools. Education: Ph.D., Biomedical Engineering, Duke University M.S., Biomedical Engineering, Duke University B.S.E., Biomedical Engineering and Electrical Engineering, Duke University Research Interests: Biomedical optics, optical coherence tomography (OCT), image-guided surgery, therapeutic monitoring, big data analytics, and high-throughput imaging for drug discovery. His work bridges engineering and medicine, emphasizing real-time feedback systems and interdisciplinary innovation. Grants & Labs: Director of the Vanderbilt Institute for Surgery and Engineering (VISE)-affiliated lab, focusing on surgical imaging and translational research. Projects include automated instrument tracking, SECTR systems, and AI-driven imaging analysis. Collaborations involve clinicians and researchers across disciplines.
Liang Zhao, PhD, MAS, MBA, is a Professor in the Department of Bioengineering and Therapeutic Sciences within the Schools of Pharmacy and Medicine at the University of California, San Francisco (UCSF). Prior to joining UCSF, he served as director of the Division of Quantitative Methods and Modeling (DQMM) in the Office of Research and Standards in the Office of Generic Drugs in the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) from 2015 to 2024. His professional career spans over 19 years with experience at Pharsight, Bristol Myers Squibb (BMS), MedImmune, and the FDA. Dr. Zhao's research focuses on pharmacometrics, drug delivery modeling, and artificial intelligence-based tools that impact drug development and regulatory decision-making. His work encompasses mechanistic models for brain drug delivery, regulatory science modeling and simulation, AI-driven drug discovery and development, drug interactions, biological availability, generic drugs, clinical pharmacology, therapeutic equivalency, computer simulation, and FDA regulatory processes. He has pioneered innovative approaches including model master files for model sharing and model-integrated evidence for generic product development and approval. His research integrates machine learning tools into pharmacometrics to advance drug delivery and bioequivalence assessment methodologies. Dr. Zhao has published over 120 articles and book chapters in prestigious journals. His recent publications demonstrate strong focus on applying advanced modeling techniques, machine learning algorithms, and pharmacometric approaches to solve complex problems in drug development and regulatory science. His work shows consistent innovation in developing quantitative methods to enhance bioequivalence assessment, improve drug product characterization, and support regulatory decision-making for generic drugs. FDA Group Recognition Award, FDA, 2024 Gary Neil Prize for Innovation in Drug Development, American Society for Clinical Pharmacology & Therapeutics (ASCPT), 2023 Commissioner's Special Citation, FDA, 2021 Humanitarian Award, Victims' Rights Foundation, 2020 30+ FDA CDER team and Individual Awards, CDER, FDA, 2011 Academic Award for Executive MBA Class 2009, Judge Business School, University of Cambridge, 2011 Dr. Zhao leads the Zhao Lab at UCSF, which advances drug development and regulatory science through cutting-edge research in pharmacometrics, drug delivery modeling, and artificial intelligence. His work bridges academic research with regulatory applications, demonstrating leadership in translating scientific innovations into practical regulatory frameworks. His experience across industry, regulatory agencies, and academia provides a unique perspective on drug development challenges and opportunities.
